Day One, 23 August 2012: Vaccines

Please enable javascript to see more information on speakers

	AFTERNOON MODULE: VACCINES
13.55	Opening remarks from the Chair Professor Nikolai Petrovsky Professor Petrovsky is Chairman of Vaxine Pty Ltd, a highly awarded Australian biotech company developing novel vaccine adjuvants. He is a Professor of Medicine at Flinders Medical Centre/Flinders University and Vice-President of the International... more.. › Professor Nikolai Petrovsky, Research Director, Vaxine
14.00	Keynote: Modern vaccine design and development Professor Nikolai Petrovsky Professor Petrovsky is Chairman of Vaxine Pty Ltd, a highly awarded Australian biotech company developing novel vaccine adjuvants. He is a Professor of Medicine at Flinders Medical Centre/Flinders University and Vice-President of the International... more.. › Professor Nikolai Petrovsky, Research Director, Vaxine
14.30	How to improve access to capital and funding Dr Carrie Hillyard Carrie is a co-founder of CM Capital and led its Life Sciences group for over 10 years. Her experience ranges from medical research to products on the market and includes mentoring entrepreneurs, assisting with commercialisation and licensing and... more.. › Dr Carrie Hillyard, Director, CM Capital Investments
15.00	Speed networking
15.30	Afternoon Refreshments
16.10	Implications of gene and cell therapy for vaccine technology- the end of an era? Dr Peter French Dr Peter French is the Chief Executive Officer of publicly listed (ASX:BLT) gene silencing company Benitec Biopharma Ltd. He has extensive experience in medical research and development spanning 33 years in cell and molecular biology and... more.. › Dr Peter French, CEO, Benitec BioPharma
16.30	Gamma Vaccines: a case study on vaccine R&D Dr Tim Hirst Tim is an entrepreneurial academic. Prior to forming Gamma Vaccines in July 2009 he was CEO of ANU Connect Ventures - a pre-seed investment fund. He has also held Senior Executive positions in universities in the United Kingdom and Australia and... more.. › Dr Tim Hirst, Executive Chairman, Gamma Vaccines
16.50	Mucosal HIV-1 vaccine - taking a vaccine from the bench to a clinical trial Dr Charani Ranasinghe I am the Group Leader of the Molecular Mucosal Vaccine Immunology Group, at the Dept of Immunology, The John Curtin School of Medical Research at the ANU. I am a full time researcher and also have research students in my laboratory. I have been... more.. › Dr Charani Ranasinghe, Researcher, The John Curtin School of Medical Research ANU
17.20	End of day